Characterization of enzymatic properties of human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits
Authors:
- 10 February 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 340 (2) , 428-434
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour TherapyCurrent Medicinal Chemistry, 2005
- Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assayBiochemical Pharmacology, 2005
- In Vitro Characterization of Enzymatic Properties and Inhibition of the p53R2 Subunit of Human Ribonucleotide ReductaseCancer Research, 2004
- Structure and function of the radical enzyme ribonucleotide reductaseProgress in Biophysics and Molecular Biology, 2001
- Mammalian p53R2 Protein Forms an Active Ribonucleotide Reductasein Vitro with the R1 Protein, Which Is Expressed Both in Resting Cells in Response to DNA Damage and in Proliferating CellsJournal of Biological Chemistry, 2001
- Controlled Protein Degradation Regulates Ribonucleotide Reductase Activity in Proliferating Mammalian Cells during the Normal Cell Cycle and in Response to DNA Damage and Replication BlocksJournal of Biological Chemistry, 2000
- A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damageNature, 2000
- pEF-BOS, a powerful mammalian expression vectorNucleic Acids Research, 1990